SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-02-024460
Filing Date
2002-06-17
Accepted
2002-06-17 15:27:43
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a2082537zsc13ga.htm SC 13G/A 87214
3 EXHIBIT 1 a2082466zex-1.htm EX-1 9650
  Complete submission text file 0000912057-02-024460.txt   99234
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 3520 DUNHILL STREET SAN DIEGO CA 92121
Business Address 3520 DUNHILL STREET SAN DIEGO CA 92121 5855974990
APPLIED MOLECULAR EVOLUTION INC (Subject) CIK: 0001111312 (see all company filings)

IRS No.: 330374014 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59733 | Film No.: 02680570
SIC: 8731 Services-Commercial Physical & Biological Research